SCHEMBL6510440

SCHEMBL6510440

COc1ccc(Sc2cc(Cl)nc(N(C)C(CC(C)C)C(=O)O)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.37
PPM1G O15355 1/20 0.37
ALOX5 P09917 1/20 0.37
PTPN1 P18031 1/20 0.37
KDM5A P29375 1/20 0.37
PPM1A P35813 1/20 0.37
PTPN9 P43378 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
MAPT P10636 2/20 0.37
SLC6A9 P48067 5/20 0.35
SIRT2 Q8IXJ6 1/20 0.34
TP53 P04637 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
CTRC Q99895 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510442 1.00 PTGES (0.37) PTGESPPM1GALOX5PTPN1KDM5A
SCHEMBL6509288 0.91 ATM (0.35) PTGESPPM1GALOX5PTPN1KDM5A
SCHEMBL6509294 0.91 ATM (0.35) PTGESPPM1GALOX5PTPN1KDM5A
SCHEMBL6508234 0.79 HPGD (0.37) MAPTTP53RXFP1SMN1; SMN2ALDH1A1
SCHEMBL6511358 0.73 NPR3 (0.45) MAPT
SCHEMBL6511364 0.73 NPR3 (0.45) MAPT
SCHEMBL6510069 0.71 HPGD (0.39) MAPTTP53RXFP1SMN1; SMN2ALDH1A1
SCHEMBL6510073 0.71 HPGD (0.39) MAPTTP53RXFP1SMN1; SMN2ALDH1A1
SCHEMBL6507668 0.71 KMT2A (0.41) MAPTTP53SMN1; SMN2ALDH1A1MEN1
SCHEMBL6514102 0.71 HPGD (0.40) MAPTTP53RXFP1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed